ArticleCancers2023

Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer.

Ahrong Ham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.